286 related articles for article (PubMed ID: 22587906)
1. Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat.
Chauvel V; Vamos E; Pardutz A; Vecsei L; Schoenen J; Multon S
Exp Neurol; 2012 Aug; 236(2):207-14. PubMed ID: 22587906
[TBL] [Abstract][Full Text] [Related]
2. Influence of ovarian hormones on cortical spreading depression and its suppression by L-kynurenine in rat.
Chauvel V; Schoenen J; Multon S
PLoS One; 2013; 8(12):e82279. PubMed ID: 24340013
[TBL] [Abstract][Full Text] [Related]
3. l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus.
Vámos E; Párdutz A; Varga H; Bohár Z; Tajti J; Fülöp F; Toldi J; Vécsei L
Neuropharmacology; 2009 Sep; 57(4):425-9. PubMed ID: 19580819
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-dependent effects of 5-hydroxytryptophan on cortical spreading depression in rat: Modelling the serotonin-ovarian hormone interaction in migraine aura.
Chauvel V; Multon S; Schoenen J
Cephalalgia; 2018 Mar; 38(3):427-436. PubMed ID: 28145727
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.
Carrillo-Mora P; Méndez-Cuesta LA; Pérez-De La Cruz V; Fortoul-van Der Goes TI; Santamaría A
Behav Brain Res; 2010 Jul; 210(2):240-50. PubMed ID: 20219555
[TBL] [Abstract][Full Text] [Related]
7. Cortical spreading depression augments kynurenate levels and reduces malonate toxicity in the rat cortex.
Kiss C; Shepard PD; Bari F; Schwarcz R
Brain Res; 2004 Mar; 1002(1-2):129-35. PubMed ID: 14988042
[TBL] [Abstract][Full Text] [Related]
8. Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers.
Ishii K; Ogaya T; Song Z; Iizuka H; Fukushima T
Chirality; 2010 Nov; 22(10):901-6. PubMed ID: 20872665
[TBL] [Abstract][Full Text] [Related]
9. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers.
Fukushima T; Sone Y; Mitsuhashi S; Tomiya M; Toyo'oka T
Chirality; 2009 Apr; 21(4):468-72. PubMed ID: 18655158
[TBL] [Abstract][Full Text] [Related]
10. Migraine preventive drugs differentially affect cortical spreading depression in rat.
Bogdanov VB; Multon S; Chauvel V; Bogdanova OV; Prodanov D; Makarchuk MY; Schoenen J
Neurobiol Dis; 2011 Feb; 41(2):430-5. PubMed ID: 20977938
[TBL] [Abstract][Full Text] [Related]
11. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats.
Nozaki K; Beal MF
J Cereb Blood Flow Metab; 1992 May; 12(3):400-7. PubMed ID: 1569135
[TBL] [Abstract][Full Text] [Related]
13. Development of a column-switching high-performance liquid chromatography for kynurenine enantiomers and its application to a pharmacokinetic study in rat plasma.
Mitsuhashi S; Fukushima T; Arai K; Tomiya M; Santa T; Imai K; Toyo'oka T
Anal Chim Acta; 2007 Mar; 587(1):60-6. PubMed ID: 17386754
[TBL] [Abstract][Full Text] [Related]
14. Modulation by kynurenine of extracellular kynurenate and glutamate in cerebral cortex of rats with acute liver failure.
Hilgier W; Kocki T; Obara-Michlewska M; Turski WA; Oja SS; Saransaari P; Albrecht J
Pharmacol Rep; 2014 Jun; 66(3):466-70. PubMed ID: 24905525
[TBL] [Abstract][Full Text] [Related]
15. Estrogen modulation of cortical spreading depression.
Kudo C; Harriott AM; Moskowitz MA; Waeber C; Ayata C
J Headache Pain; 2023 May; 24(1):62. PubMed ID: 37237336
[TBL] [Abstract][Full Text] [Related]
16. Systemic L-kynurenine administration partially protects against NMDA, but not kainate-induced degeneration of retinal ganglion cells, and reduces visual discrimination deficits in adults rats.
Vorwerk CK; Kreutz MR; Dreyer EB; Sabel BA
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2382-92. PubMed ID: 8933755
[TBL] [Abstract][Full Text] [Related]
17. Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats.
Santamaría A; Ríos C; Solís-Hernández F; Ordaz-Moreno J; González-Reynoso L; Altagracia M; Kravzov J
Neuropharmacology; 1996 Jan; 35(1):23-8. PubMed ID: 8684593
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
19. Chronic daily cortical spreading depressions suppress spreading depression susceptibility.
Sukhotinsky I; Dilekoz E; Wang Y; Qin T; Eikermann-Haerter K; Waeber C; Ayata C
Cephalalgia; 2011 Dec; 31(16):1601-8. PubMed ID: 22013142
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effect of chronic peroral topiramate on potassium-induced cortical spreading depression in rats.
Unekawa M; Tomita Y; Toriumi H; Suzuki N
Cephalalgia; 2012 May; 32(7):518-27. PubMed ID: 22523186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
